跳至主要内容
临床试验/NCT02278016
NCT02278016Unknown不适用

Diagnosis Value of Procalcitonin, Interleukin-6, AgiotensininⅡin the Cerebrospinal Fluid of Patients With Central Nervous System Infective Diseases

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
150
试验地点
1
主要终点
Levels of procalcitonin, interleukin-6, agiotensininⅡ in the serum and cerebrospinal fluid

研究概览

简要总结

Bacterial meningitis is a potentially life-threatening disease that is associated with substantial neurological morbidity and mortality. Accurate diagnosis is essential to improve outcome and prevent antibiotic overuse. Here we try to explore new biological markers for the diagnosis of the central nervous system infection disease.

详细描述

To investigate the diagnosis value of procalcitonin,interleukin-6, agiotensininⅡin the cerebrospinal fluid in the central nervous system infection disease.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 13 years or older;
  • At least two of the following clinical characteristics:headache, fever, neck stiffness, mental symptoms or consciousness impairment or seizures
  • Patients' family signed informed consent.

排除标准

  • Contraindications to lumbar puncture
  • Patients with active malignancy

结局指标

主要结局

Levels of procalcitonin, interleukin-6, agiotensininⅡ in the serum and cerebrospinal fluid

时间窗: 36 months

meet the clinical diagnostic criteria for the central nervous system infection disease, the blood and cerebrospinal fluid samples after onset.

次要结局

未报告次要终点

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验